Associations and interactions between bare lymphocyte syndrome factors

Molecular and Cellular Biology

Volumn 20, Issue 17, 2000, Pages 6587-6599

  DeSandro, A M ^a   Nagarajan, U M ^a   Boss, J M ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; PROLINE; PROTEIN SUBUNIT; TRANSACTIVATOR PROTEIN;

ARTICLE; BARE LYMPHOCYTE SYNDROME; COMBINED IMMUNODEFICIENCY; DNA BINDING; GENE CONTROL; GENE MUTATION; HUMAN; HUMAN CELL; MUTAGENESIS; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN PROTEIN INTERACTION; TRANSACTIVATION;

ANIMALS; ANKYRINS; CELL LINE; COS CELLS; DNA; DNA-BINDING PROTEINS; FLOW CYTOMETRY; GENES, MHC CLASS II; GENES, REPORTER; GLUTATHIONE TRANSFERASE; HUMANS; MUTAGENESIS; NUCLEAR PROTEINS; PLASMIDS; PRECIPITIN TESTS; PROLINE; PROTEIN BINDING; PROTEIN STRUCTURE, SECONDARY; PROTEIN STRUCTURE, TERTIARY; RECOMBINANT FUSION PROTEINS; SEVERE COMBINED IMMUNODEFICIENCY; TRANS-ACTIVATION (GENETICS); TRANS-ACTIVATORS; TRANSCRIPTION FACTORS; TRANSFECTION;

EID: 0033838113     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.20.17.6587-6599.2000     Document Type: Article

References (55)

1. Gapped BLAST and PSI-BLAST: A new generation of protein database search programs
2. HLA gene amplification and hybridization analysis of polymorphism. HLA matching for bone marrow transplantation of a patient with HLA-deficient severe combined immunodeficiency syndrome
3. Class II-antigen-negative patient and mutant B-cell lines represent at least three, and probably four, distinct genetic defects defined by complementation analysis
4. Regulation of transcription of MHC class II genes
5. Mutational analysis of the MHC class II transactivator (CIITA) indicates a functional requirement for conserved LCD motifs and for interactions with the conserved W-box promoter element
6. Class II transactivator (CIITA) is sufficient for the inducible expression of major histocompatibility complex class II genes
7. Molecular analysis of G1B and G3A IFN-γ mutants reveals that defects in CIITA or RFX result in defective class II MHC and Ii gene induction
8. Immune interferon activates multiple class II major histocompatibility complex genes and the associated invariant chain gene in human endothelial cells and dermal fibroblasts
9. The bare lymphocyte syndrome: Molecular clues to the transcriptional regulation of major histocompatibility complex class II genes
10. RFXAP, a novel subunit of the RFX DNA binding complex, is mutated in MHC class II deficiency
11. Major histocompatibility complex class II deficiency: A clinical review
12. Mutation and modeling analysis of Saccharomyces cerevisiae Swi6 ankyrin repeats
13. Structure of the winged-helix protein hRFX1 reveals a new mode of DNA binding
14. Stable variants affecting B cell alloantigens in human lymphoid cells
15. Combined immunodeficiency with defective expression in MHC class II genes
16. Protease treatment of nuclear extracts distinguishes between class II major histocompatibility complex X1 box DNA-binding proteins in wild type and class II deficient B cells
17. Regulatory factor-X binding to mutant HLA-DRA promoter sequences
18. Protein family classification based on searching a database of blocks
19. The DNA-binding defect observed in major histocompatibility complex class II regulatory mutants concerns only one member of a family of complexes binding to the X boxes of class II promoters
20. The PROSITE database, its status in 1999
21. The crystal structure of the I Kappa B alpha/NF-Kappa B complex reveals mechanisms of NF-Kappa B inactivation
22. Complex architecture of major histocompatibility complex class II promoters: Reiterated motifs and conserved protein-protein interactions
23. Structure of an I kappa B alpha/NF-kappa B complex
24. In vivo footprinting of MHC class II genes: Bare promoters in the bare lymphocyte syndrome
25. Developmental and cytokine-mediated regulation of MHC class II gene promoter occupancy in vivo
26. NF-X, a transcription factor implicated in MHC class II gene regulation
27. The scanning model for translation: An update
28. The Ankyrin repeat-containing adaptor protein Tvl-1 is a novel substrate and regulator of Raf-1
29. A defect in the regulation of major histocompatibility complex class II gene expression in human HLA-DR negative lymphocytes from patients with combined immunodeficiency syndrome
30. Formation of a regulatory factor X/X2 box-binding protein/nuclear factor-Y multiprotein complex on the conserved regulatory regions of HLA class II genes
31. Regulation of MHC class II genes: Lessons from a disease
32. MHC class II-deficient combined immunodeficiency: A disease of gene regulation
33. A gene encoding a novel RFX-associated transactivator is mutated in the majority of MHC class II deficiency patients
34. CREB regulates MHC class II expression in a CIITA-dependent manner
35. Purified X2BP cooperatively binds the class II MHC X box region in the presence of purified RFX, the X box factor deficient in the bare lymphocyte syndrome
36. RFX, a bare lymphocyte syndrome transcription factor, is a multimeric phosphoprotein complex
37. MHC class II gene silencing in trophoblast cells is caused by inhibition of CIITA expression
38. RFX-B is the gene responsible for the most common cause of the bare lymphocyte syndrome, a MHC class II immunodeficiency
39. Novel mutations within the RFX-B gene and partial rescue of MHC and related genes through exogenous class II transactivator in RFX-B-deficient cells
40. SWISS-MODEL and the Swiss-PdbViewer: An environment for comparative protein modelling
41. Congenital immunodeficiency with a regulatory defect in MHC class II gene expression lacks a specific HLA-DR promoter binding protein, RF-X
42. Function of major histocompatibility complex class II promoters requires cooperative binding between factors RFX and NF-Y
43. Class II MHC transcriptional mutants are defective in higher order complex formation
44. Activation of class II MHC genes requires both the X box region and the class II transactivator (CIITA)
45. Specific complex formation between the type II bare lymphocyte syndrome-associated transactivators CIITA and RFX5
46. Genetic complexity of regulatory mutants defective for HLA class II expression
47. Pfam: Multiple sequence alignments and HMM-profiles of protein domains
48. A novel DNA-binding regulatory factor is mutated in primary MHC class II deficiency (bare lymphocyte syndrome)
49. Complementation cloning of an MHC class II transactivator mutated in hereditary MHC class II deficiency (or bare lymphocyte syndrome)
50. Regulation of MHC class II expression by interferon-gamma mediated by the transactivator gene CIITA
51. Defective HLA DRA X box binding in the class II transactive transcription factor mutant 6.1.6 and in cell lines from class II immunodeficient patients
52. Orientation and positional mapping of the subunits of the multicomponent transcription factors RFX and X2BP to the major histocompatibility complex class II transcriptional enhancer
53. The upstream activator CTF/NF1 and RNA polymerase II share a common element involved in transcriptional activation
54. Two distinct genetic loci regulating class II gene expression are defective in human mutant and patient cell lines
55. Human MHC class II gene transcription directed by the carboxyl terminus of CIITA, one of the defective genes in type II MHC combined immune deficiency